Drugs / PF-07921188
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05703607 | Jan 2023 → Sep 2025 | herpes zoster | Pfizer | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-07921188 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05703607 ↗ |
| Modality | Messenger RNA (mRNA) | “modified RNA vaccine” NCT05703607 ↗ |
| Route | Intramuscular | “Intramuscular injection” NCT05703607 ↗ |